KW-136 With Sofosbuvir for Chinese Adults With Chronic Hepatitis C

Condition:   Hepatitis C, Chronic Interventions:   Drug: KW-136 capsule;   Drug: Sofosbuvir Sponsors:   Kawin Technology Share-holding Co., Ltd.;   KawinGreen Biotech Co., Ltd. Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials